Investment

Features

Fees Safety

Academy

Pluang+

Home/News Feed/Hims & Hers shares drop 15.7% after Q1 loss widens and weak revenue forecast.

HIMS

$36.84

-$0.33 -0.89%

Hims & Hers shares drop 15.7% after Q1 loss widens and weak revenue forecast.

Company Fundamentals

12 May 2026

CNBC

View Source

Bearish

Telehealth company Hims & Hers saw its stock fall 15.7% in premarket trading after reporting a first-quarter net loss of $92 million, nearly double last year's $50 million loss. Revenue rose 4% to $608 million, but average monthly revenue per subscriber declined. The company forecast second-quarter revenue between $680 million and $700 million and full-year revenue up to $3 billion, with adjusted EBITDA expected to reach $55 million in Q2 and $350 million for the year. Analysts noted the outlook was mixed and highlighted a transition as Hims reduces reliance on compounded GLP-1 weight loss drugs following a deal with Novo Nordisk to sell branded Wegovy on its platform.

More News (HIMS)

Law firm investigates Hims & Hers for allegedly sharing users' private health data without consent.

Lowey Dannenberg, P.C. is investigating Hims & Hers Health, Inc. for allegedly sharing sensitive user health data, including medical histories and mental health info, with third parties without proper consent. This raises concerns about violations of...

Market News

Bearish

16 hours ago